WORKSHOP: Drugs, standards and chronic illness
WORKSHOP: Drugs, standards and chronic illness
27-28 November 2009
A two-day meeting held at the Centre for the History of Science, Technology and Medicine, University of Manchester.
http://www.chstm.manchester.ac.uk/newsandevents/conferences/drugsstandards/
Sponsored by the Research Networking Programme 'Standard Drugs and Drug Standards' of the European Science Foundation, with additional funding from the Wellcome Trust.
Attendance is free, but please contact the organisers as places are limited.
Carsten Timmermann: carsten.timmermann@manchester.ac.uk
Viviane Quirke: viviane.quirke@brookes.ac.uk
PROVISIONAL PROGRAMME
FRIDAY, 27 NOVEMBER
9:00 welcome
Session I - Therapeutics and the changing meanings of chronic illness
9:15
Christian Bonah and Nicolas Tschudy (University of Strasbourg) Of cattle, rats and men: A comparative history of laboratory and clinical developments of anti-vitamin K (Warfarin) in the US and France, 1930s-1970s
10:00
Carla Keirns (University of Michigan, Ann Arbor) Measured breath: Symptoms, spirometry and treatments for asthma and other chronic lung diseases
10:45 coffee break
11:00
Nicolas Henckes (CERMES, Paris)
Chronicity, neuroleptics and the changing meaning of therapeutic in French psychiatry, 1950-1975
11:45
Jason Szabo (McGill University, Montreal) From death sentence to chronic disease: Protease inhibitors and the transformation of the Acquired Immunodeficiency Syndrome
12:30 lunch break
Session II - Re-assessing risk: twentieth century models for understanding chronic illness
14:00
George Weisz (McGill University, Montreal) The US National Health Survey on Chronic Disease
14:45
Elodie Giroux (Lyon III University)
Framingham and afterwards: The emergence of the notion of risk factor in the US and Britain
15:30 coffee break
16:00
Gerald M. Oppenheimer (City University of New York and Columbia University) Taking on risk: Coronary heart disease and randomized clinical trials in the 1960s
16:45
Teun Zuiderent-Jerak (Erasmus University Rotterdam) The issues, the evidence and their partial (dis-)connections: On the composition of the common good in guideline production
17:30
Commentary: Jeremy Greene (Harvard University, Cambridge, MA)
SATURDAY, 28 NOVEMBER
Session III - Standardizing patients and normalizing illness
9:00
Aaron Pascal Mauck (Harvard University, Cambridge, MA) The Institutionalization of type 2 diabetes risk in comparative perspective
9:45
Ulrike Thoms (Charité, Berlin)
Diabetes, insulin and the role of patient organisations in Germany.
1930-1980
10:30 coffee break
11:00
Isabelle Baszanger (CERMES, Paris)
Between ‘survivorship’ and ‘living with dying’: recreating normality in oncology
11:45
Carsten Timmermann (University of Manchester) ‘Because something had to be done’: Lung cancer, chemotherapy, and how to deal with a recalcitrant disease, circa 1960-1990
12:30 lunch break
Session IV - Making sense of difference
14:00
Tricia Close-Koenig (University of Strasbourg) Classification systems of cancer: Standardized and standardizing
14:45
Viviane Quirke (Oxford Brookes University) Different yet the same? Developing drugs for the treatment of heart disease and cancer at Imperial Chemical Industries, 1950s-1980s
15:30
Bas Peters, Anke-Hilse Maitland-Van der Zee (University of Utrecht) and Toine Pieters (VU Medical Center, Amsterdam) Pharmacogenetics in flux: Cardiovascular medicine and managing genetic differences, 1950-2009
16:15: end of workshop
--
Carsten Timmermann, PhD
Centre for the History of Science, Technology and Medicine The University of Manchester, Simon Building, Room 2.36 Manchester M13 9PL, United Kingdom Phone +44-(0)161-275 7950 Fax +44-(0)161-275 5699 http://www.manchester.ac.uk/chstm http://www.cancer-history.org
27-28 November 2009
A two-day meeting held at the Centre for the History of Science, Technology and Medicine, University of Manchester.
http://www.chstm.manchester.ac.uk/newsandevents/conferences/drugsstandards/
Sponsored by the Research Networking Programme 'Standard Drugs and Drug Standards' of the European Science Foundation, with additional funding from the Wellcome Trust.
Attendance is free, but please contact the organisers as places are limited.
Carsten Timmermann: carsten.timmermann@manchester.ac.uk
Viviane Quirke: viviane.quirke@brookes.ac.uk
PROVISIONAL PROGRAMME
FRIDAY, 27 NOVEMBER
9:00 welcome
Session I - Therapeutics and the changing meanings of chronic illness
9:15
Christian Bonah and Nicolas Tschudy (University of Strasbourg) Of cattle, rats and men: A comparative history of laboratory and clinical developments of anti-vitamin K (Warfarin) in the US and France, 1930s-1970s
10:00
Carla Keirns (University of Michigan, Ann Arbor) Measured breath: Symptoms, spirometry and treatments for asthma and other chronic lung diseases
10:45 coffee break
11:00
Nicolas Henckes (CERMES, Paris)
Chronicity, neuroleptics and the changing meaning of therapeutic in French psychiatry, 1950-1975
11:45
Jason Szabo (McGill University, Montreal) From death sentence to chronic disease: Protease inhibitors and the transformation of the Acquired Immunodeficiency Syndrome
12:30 lunch break
Session II - Re-assessing risk: twentieth century models for understanding chronic illness
14:00
George Weisz (McGill University, Montreal) The US National Health Survey on Chronic Disease
14:45
Elodie Giroux (Lyon III University)
Framingham and afterwards: The emergence of the notion of risk factor in the US and Britain
15:30 coffee break
16:00
Gerald M. Oppenheimer (City University of New York and Columbia University) Taking on risk: Coronary heart disease and randomized clinical trials in the 1960s
16:45
Teun Zuiderent-Jerak (Erasmus University Rotterdam) The issues, the evidence and their partial (dis-)connections: On the composition of the common good in guideline production
17:30
Commentary: Jeremy Greene (Harvard University, Cambridge, MA)
SATURDAY, 28 NOVEMBER
Session III - Standardizing patients and normalizing illness
9:00
Aaron Pascal Mauck (Harvard University, Cambridge, MA) The Institutionalization of type 2 diabetes risk in comparative perspective
9:45
Ulrike Thoms (Charité, Berlin)
Diabetes, insulin and the role of patient organisations in Germany.
1930-1980
10:30 coffee break
11:00
Isabelle Baszanger (CERMES, Paris)
Between ‘survivorship’ and ‘living with dying’: recreating normality in oncology
11:45
Carsten Timmermann (University of Manchester) ‘Because something had to be done’: Lung cancer, chemotherapy, and how to deal with a recalcitrant disease, circa 1960-1990
12:30 lunch break
Session IV - Making sense of difference
14:00
Tricia Close-Koenig (University of Strasbourg) Classification systems of cancer: Standardized and standardizing
14:45
Viviane Quirke (Oxford Brookes University) Different yet the same? Developing drugs for the treatment of heart disease and cancer at Imperial Chemical Industries, 1950s-1980s
15:30
Bas Peters, Anke-Hilse Maitland-Van der Zee (University of Utrecht) and Toine Pieters (VU Medical Center, Amsterdam) Pharmacogenetics in flux: Cardiovascular medicine and managing genetic differences, 1950-2009
16:15: end of workshop
--
Carsten Timmermann, PhD
Centre for the History of Science, Technology and Medicine The University of Manchester, Simon Building, Room 2.36 Manchester M13 9PL, United Kingdom Phone +44-(0)161-275 7950 Fax +44-(0)161-275 5699 http://www.manchester.ac.uk/chstm http://www.cancer-history.org